OMEGA HEALTHCARE REPORTS OFFICER/DIRECTOR CHANGES, COMP PLANS
Ticker: OHI · Form: 8-K · Filed: Jan 2, 2024 · CIK: 888491
| Field | Detail |
|---|---|
| Company | Omega Healthcare Investors Inc (OHI) |
| Form Type | 8-K |
| Filed Date | Jan 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, executive-compensation, leadership-change
TL;DR
**OMEGA HEALTHCARE just filed an 8-K about leadership changes and exec pay.**
AI Summary
OMEGA HEALTHCARE INVESTORS, INC. filed an 8-K on January 2, 2024, reporting an event that occurred on January 1, 2024. The filing indicates information regarding the departure or election of directors or officers, and compensatory arrangements for certain officers. This matters to investors as changes in leadership and executive compensation can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.
Why It Matters
Changes in executive leadership and compensation structures can directly influence a company's strategic direction and operational efficiency, which are key drivers of long-term shareholder value.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of corporate governance changes, not an announcement of adverse financial events.
Analyst Insight
Investors should monitor subsequent filings or company announcements for specific details regarding the changes in directors/officers and compensatory arrangements to understand their potential impact on the company's future strategy and financial health.
Key Players & Entities
- OMEGA HEALTHCARE INVESTORS, INC. (company) — the registrant filing the 8-K
- January 1, 2024 (date) — date of the earliest event reported
- January 2, 2024 (date) — date the 8-K was filed
- Maryland (company) — state of incorporation for OMEGA HEALTHCARE INVESTORS, INC.
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 1, 2024, as stated in the 'Date of Report (Date of earliest event reported): January 1, 2024' section.
What specific items are disclosed in this 8-K filing by OMEGA HEALTHCARE INVESTORS, INC.?
The 8-K filing discloses information under 'ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'ITEM INFORMATION: Financial Statements and Exhibits'.
What is the full business address of OMEGA HEALTHCARE INVESTORS, INC. as listed in the filing?
The full business address is 303 International Circle, Suite 200, Hunt Valley, Maryland 21030, with a business phone number of (410) 427-1700.
Is OMEGA HEALTHCARE INVESTORS, INC. considered an 'emerging growth company' according to this filing?
No, the filing indicates that OMEGA HEALTHCARE INVESTORS, INC. is not an 'emerging growth company' as the box for 'Emerging growth company' is checked with a strikethrough (¨), implying it does not apply.
What is the SEC File Number for OMEGA HEALTHCARE INVESTORS, INC.?
The SEC File Number for OMEGA HEALTHCARE INVESTORS, INC. is 001-11316, as listed under the company's identification details.
Filing Stats: 455 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-01-02 08:00:39
Filing Documents
- tm2333150d1_8k.htm (8-K) — 25KB
- 0001104659-24-000116.txt ( ) — 194KB
- ohi-20240101.xsd (EX-101.SCH) — 3KB
- ohi-20240101_lab.xml (EX-101.LAB) — 33KB
- ohi-20240101_pre.xml (EX-101.PRE) — 22KB
- tm2333150d1_8k_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEGA HEALTHCARE INVESTORS, INC. Dated: January 2, 2024 By: /s/ Gail D. Makode Gail D. Makode Chief Legal Officer, General Counsel